vTv Therapeutics (VTVT) Cash from Operations (2014 - 2026)
vTv Therapeutics (VTVT) reported Cash from Operations of 9154000.0 for Q1 2026, up 260.96% on a YoY basis from 2535989.77 in Q1 2025, and up 198.95% sequentially from 9251000.0 in Q4 2025.
vTv Therapeutics (VTVT) Cash from Operations (2014 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 13 years of Cash from Operations data on file, last reported at 9154000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 260.96% year-over-year to 9154000.0; the trailing twelve-month figure through Mar 2026 stood at 10414000.0 (up 55.98% YoY), and the FY2025 full-year result was 25255000.0, changed 0.21% from the prior year.
- Cash from Operations grew to 9154000.0 in Q1 2026, from 9251000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 9154000.0 in Q1 2026 to a low of 9251000.0 in Q4 2025.
- A 5-year average of 4500647.06 and a median of 5222000.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations slumped 973.51% in 2023 and surged 260.96% in 2026, its largest moves.
- Tracing VTVT's Cash from Operations over 5 years: stood at 6880000.0 in 2022, then soared by 57.65% to 2914000.0 in 2023, then slumped by 65.58% to 4825000.0 in 2024, then plunged by 91.73% to 9251000.0 in 2025, then surged by 198.95% to 9154000.0 in 2026.
- Business Quant data shows VTVT's Cash from Operations at 9154000.0 in Q1 2026, 9251000.0 in Q4 2025, and 5222000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 9.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.15 Mn |
| Mar 31, 2026 | 9.15 Mn |
| Dec 31, 2025 | -9.25 Mn |
| Dec 31, 2025 | -9.25 Mn |
| Sep 30, 2025 | -5.22 Mn |
| Sep 30, 2025 | -5.22 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Mar 31, 2025 | -5.69 Mn |
| Mar 31, 2025 | -5.69 Mn |
| Dec 31, 2024 | -4.83 Mn |
| Dec 31, 2024 | -4.83 Mn |
| Sep 30, 2024 | -6.42 Mn |
| Sep 30, 2024 | -6.42 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Jun 30, 2024 | -6.73 Mn |
| Mar 31, 2024 | -7.34 Mn |
| Mar 31, 2024 | -7.34 Mn |
| Dec 31, 2023 | -2.91 Mn |
| Dec 31, 2023 | -2.91 Mn |